-
Boehringer Ingelheim patents new QPCT and QPCTL inhibitors
04 Sep 2025 22:13 GMT
Cancer
Boehringer Ingelheim Pharma GmbH & Co. KG …
-
Boehringer Ingelheim Hernexeos approved in China for previously treated patients with HER2-mutant advanced NSCLC
02 Sep 2025 09:08 GMT
Boehringer Ingelheim has received approval for HERNEXEOS ( … Board of Managing Directors at Boehringer Ingelheim. “Given the robust clinical evidence …
-
China NMPA approves Boehringer Ingelheim's Hernexeos as first oral targeted therapy for previously treated patients with HER2─mutant advanced NSCLC
02 Sep 2025 07:35 GMT
… board of managing directors at Boehringer Ingelheim. “Given the robust clinical … compared with standard of care.
Boehringer Ingelheim’s clear aspiration – to … personal, today and for generations.
Boehringer Ingelheim is a biopharmaceutical company active …
-
Boehringer Ingelheim broadens Jardiance access to chronic kidney disease
02 Sep 2025 05:29 GMT
Jardiance (ingredient: empagliflozin), Boehringer Ingelheim’s SGLT-2 inhibitor, has … proteinuria could further broaden access.”
Boehringer Ingelheim Korea Medical Lead Lee Gun … Boy, President and CEO of Boehringer Ingelheim Korea, emphasized the company’s …
-
General : 'Zero By 30'Â Global Goal:Â Boehringer Ingelheim Ramps Up 'Stop Rabies Campaign'Â In Bintulu
25 Aug 2025 08:27 GMT
… media statement issued by Boehringer Ingelheim Malaysia.
The statement also … Head of Animal Health for Boehringer Ingelheim Malaysia, Singapore & Indonesia … Generations (SD4G) framework of Boehringer Ingelheim, a German-pioneered biopharmaceutical …
-
Winners: 2025 New Zealand Primary Healthcare Awards | He Tohu Mauri Ora
14 Sep 2025 01:40 GMT
… access with compassion and integrity.”
Boehringer Ingelheim Nurse Practitioner of the Year …
-
Boehringer Ingelheim, AnGes Ink Deal to Produce Next-Generation PAD Gene Therapy
22 Aug 2025 04:34 GMT
… 47;www.boehringer-ingelheim.com/partnering/boehringer-ingelheim-bioxcellence… #47;LXCEiHNQqHR21aa9eVeHAvboVaLyWbcO.pdf
Boehringer Ingelheim and Palatin Technologies … -boehringer-ingelheim-105-million-spevigo
Echosens and Boehringer Ingelheim Expand …
-
The data-driven digital journey defining Boehringer Ingelheim
22 Aug 2025 11:02 GMT
This technology makes it easier to obtain maximum value from the data and solves the problems of previous generations, adds Sanz. “The strategy includes an actionable data governance model, which helps ensure data quality and consistency for different use …
-
Boehringer Ingelheim & AnGes sign manufacturing agreement for HGF gene therapy product
21 Aug 2025 05:43 GMT
… and future patient access.
Boehringer Ingelheim BioXcellence, the biopharmaceutical contract … the continued collaboration with Boehringer Ingelheim BioXcellence will accelerate the … -term corporate value.
Boehringer Ingelheim is a biopharmaceutical company …
-
Boehringer Ingelheim, Palatin Technologies Partner to Develop Melanocortin Receptor Therapy for Retinal Diseases
20 Aug 2025 16:30 GMT
Boehringer Ingelheim and Palatin Technologies, Inc. have … , Head of Eye Health at Boehringer Ingelheim, emphasized the urgent need for … in retinal health. He praised Boehringer Ingelheim’s expertise and global reach …
About
© 1995-2025